reviewTop 1% cited
An overview of recent studies on the analysis of pharmaceutical polymorphs
Journal of Pharmaceutical and Biomedical Analysis · 2010 · Vol. 55(4) · pp. 618–644
Norman Chieng(University of Connecticut)Thomas Rades(University of Otago)Jaakko Aaltonen✉(University of Eastern Finland)
Drug Solubulity and Delivery SystemsCrystallization and Solubility StudiesAnalytical Chemistry and ChromatographyChemistrySolid-stateCocrystalCharacterization (materials science)CrystallizationNanotechnologyBiochemical engineeringPhysical chemistryOrganic chemistryMaterials science
MeSH terms
CalorimetryChemistry Techniques, AnalyticalChemistry, PharmaceuticalCrystallizationMicroscopySolventsSpectrophotometrySpectrum Analysis, RamanX-Ray Diffraction
Citations
275
FWCI
8.95
field-weighted impact
References
274
Percentile
99%
vs. same field & year
Citations per year
References
What is the True Solubility Advantage for Amorphous Pharmaceuticals?
Pharmaceutical Research · 2000 · 1,334 citations
Applying Hot-Stage Microscopy to Co-Crystal Screening: A Study of Nicotinamide with Seven Active Pharmaceutical Ingredients
Crystal Growth & Design · 2008 · 343 citations
Use of a Glutaric Acid Cocrystal to Improve Oral Bioavailability of a Low Solubility API
Pharmaceutical Research · 2006 · 685 citations
Amorphous pharmaceutical solids: preparation, characterization and stabilization
Advanced Drug Delivery Reviews · 2001 · 1,366 citations
Diversity in Single- and Multiple-Component Crystals. The Search for and Prevalence of Polymorphs and Cocrystals
Crystal Growth & Design · 2007 · 533 citations
Polymorphism in Carbamazepine Cocrystals
Crystal Growth & Design · 2008 · 265 citations
Trends in Solubility of Polymorphs
Journal of Pharmaceutical Sciences · 2005 · 497 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.